波士顿讯—Ginkgo Bioworks Holdings, Inc. (NYSE: DNA )的首席会计官Steven P. Coen近期出售了该公司A类普通股，总价值约4,933美元。此次交易发生于2月4日，涉及以平均每股13.443美元的价格出售367股。在DNA股价2025年迄今上涨超过66%的强劲表现背景下完成了这笔交易。

马萨诸塞州波士顿 - 根据最近的SEC文件显示，Ginkgo Bioworks Holdings, Inc. (NYSE: DNA )的首席财务官Mark E. Dmytruk进行了一次股票交易。在公司股票年初至今上涨66.6%的强劲势头下进行了此次交易。根据 InvestingPro ...

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the ...

BOSTON—Steven P. Coen, the Chief Accounting Officer at Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), recently sold shares of the company's Class A Common Stock valued at approximately $4,933. The ...

北京时间2025年1月17日，Ginkgo Bioworks Holdings, Inc.（股票代码：DNA.us）在美股市场上经历了显著的股价波动，盘中急速上升5%，当前报9.77美元/股，成交量达33.0462万股，换手率为0.57%，振幅则达7.66%。这一市场表现引发了投资者的广泛关注，尤其是在当前生物技术行业整体小幅下跌0.16%的背景下，这一异动格外引人注目。

Boston, MA – Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) recently reported a stock transaction by its Chief Financial Officer, Mark E. Dmytruk, according to a recent SEC filing. The transaction comes as ...

Ginkgo Bioworks faces ongoing revenue declines and high cash burn, despite cost-cutting efforts. Find out why I maintain a ...

北京时间2025年02月01日04时02分，Ginkgo Bioworks Holdings, Inc.（DNA.us）股票出现波动，股价大幅下跌5.00%。截至发稿，该股报13.22美元/股，成交量117.432万股， 换手率 2.04%，振幅9.78%。

Ginkgo Bioworks Holdings, Inc.’s DNA share price has surged by 14.49%, which has investors questioning if this is right time ...

Ginkgo Bioworks Holdings, Inc.’s DNA share price has dipped by 16.38%, which has investors questioning if this is right time to buy.

TD Cowen analyst Brendan Smith raised the firm’s price target on Ginkgo Bioworks (DNA) to $16 from $10 and keeps a Buy rating on the shares.